One study found that DTI metrics, including FA, were more sensitive than NODDI measurements to early WM tract abnormalities in Alzheimer's disease (AD), although another found that NODDI measurements showed better relationships to tau pathology in AD (Weston et al., 2023). The gene discussed is MAPT; the disease is Alzheimer disease.